516096 SANPA

Sangal Papers Share Price

₹211.00 -0.8 (-0.38%)

11 Mar, 2025 12:34

SIP TrendupStart SIP in SANPA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -9.48%
  • Over 3 Month -28.52%
  • Over 6 Month -11.49%
  • Over 1 Year + 6.06%
SIP Lightning

Smart Investing Starts Here Start SIP with Sangal Papers for Steady Growth!

Invest Now

Sangal Papers Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Sangal Papers Financials

Sangal Papers Technicals

EMA & SMA

Current Price
₹211.00
-0.8 (-0.38%)
pointer
  • stock-down_img
  • Bearish Moving Average 10
  • stock-up_img
  • Bullish Moving Average 6
  • 20 Day
  • ₹212.21
  • 50 Day
  • ₹235.79
  • 100 Day
  • ₹247.46
  • 200 Day
  • ₹241.62

Resistance and Support

211.33 Pivot Speed
  • R3 212.67
  • R2 212.33
  • R1 211.67
  • S1 210.67
  • S2 210.33
  • S3 209.67

What's your outlook on Sangal Papers?

You can only vote for once

Sangal Papers Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-13 Quarterly Results
2024-11-12 Quarterly Results
2024-08-13 Quarterly Results
2024-05-30 Audited Results
2024-02-13 Quarterly Results

Sangal Papers F&O

Sangal Papers Shareholding Pattern

No data available.

About Sangal Papers

  • NSE Symbol
  • SANPA
  • BSE Symbol
  • 516096
  • ISIN
  • INE384D01022

Similar Stocks to Sangal Papers

Sangal Papers FAQs

Sangal Papers share price is ₹211 As on 11 March, 2025 | 12:20

The Market Cap of Sangal Papers is ₹27.6 Cr As on 11 March, 2025 | 12:20

The P/E ratio of Sangal Papers is 8.5 As on 11 March, 2025 | 12:20

The PB ratio of Sangal Papers is 0.7 As on 11 March, 2025 | 12:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23